Review paper on intermittent vs continuous treatment in the maintenance treatment setting of metastatic colorectal cancer
Review paper on intermittent vs continuous treatment in the maintenance treatment setting of metastatic colorectal cancer
Prof. Tanios Bekaii-Saab, Assoc. Prof. Yu Sunakawa, Dr. Sebastian Stintzing
GI CONNECT members authored a paper ‘Reconsidering the benefit of intermittent versus continuous treatment in the maintenance treatment setting of metastatic colorectal cancer’ with the aim to reconsider the evidence for clinical benefit of intermittent versus continuous treatment in the maintenance treatment setting of mCRC and to evaluate the effect of RAS and BRAF mutational status on maintenance strategies. Access the paper published in Cancer Treatment Reviews and download slides of the key highlights.
Prof. Tanios Bekaii-Saab
Medical Oncologist
Mayo Clinic
United States (US)
Assoc. Prof. Yu Sunakawa
Medical Oncologist
St Marianna University
Japan
Dr. Sebastian Stintzing
GI Medical Oncologist
Charité Universitaetsmedizin
Germany
Now Published | 
0 min
|
2016
download resources
I agree that this educational programme:
GI CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer.
Other programmes of interest
10 min
Other programmes developed by Assoc. Prof. Yu Sunakawa
Assoc. Prof. Yu Sunakawa
Medical Oncologist
St Marianna University
Japan
Other programmes developed by Dr. Sebastian Stintzing
Dr. Sebastian Stintzing
GI Medical Oncologist
Charité Universitaetsmedizin
Germany
